Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease

Abstract

In this study, inhibition of lymphocyte trafficking was a specific and potentially effective new strategy to prevent visceral acute GVHD. (Funded by Pfizer and others; ClinicalTrials.gov number, NCT00948753.).